The first COPD patient has been dosed in a Phase 1b COPD trial testing Bambusa Therapeutics’ dual-target therapy BBT002.

Columnist Caroline Gainer remembers a horseback ride that taught her a lesson about how to respond when you find yourself ...

Mabwell’s experimental therapy 9MW1911 may reduce the frequency of moderate to severe exacerbations in people with chronic obstructive pulmonary disease (COPD), according to data from a completed ...

As is true with almost everything concerning my chronic obstructive pulmonary disease (COPD), my mental health requires some effort on my part. Just as I monitor my breath, adjust my pace, and adapt ...

The American Lung Association Research Institute is investing $22 million to advance research and support care for lung disease, including chronic obstructive pulmonary disease (COPD). “Research is ...

November marks COPD Awareness Month in the U.S. — a time, advocates say, to educate communities, inspire action, and support those with chronic obstructive pulmonary disease (COPD). World COPD Day ...

“Gloom, despair, and agony on me …” The Moonshiner quartet sang it best on the country show “Hee Haw,” their voices twanging through the television like a knowing wink from the universe. I used to ...

Inflammation is having a moment. It’s the buzzword behind turmeric lattes, elimination diets, and supplement stacks. But for those of us living with chronic obstructive pulmonary disease (COPD), ...

Caroline Gainer is from West Virginia, the state with the highest rate of COPD in the United States. She was diagnosed with moderate-to-severe COPD in 2013 after a pneumothorax (lung collapse). After ...

Using e-cigarettes, often called vaping, significantly increases the risk of chronic obstructive pulmonary disease (COPD), a U.S. study suggests. People who used e-cigarettes, which are ...

I remember how hard it was to keep cars, or any other outdoor metal object, clean and looking good when I lived in the steel town of Weirton, West Virginia. That ongoing struggle reminds me of my ...

The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as ...